Literature DB >> 10552930

Human indolethylamine N-methyltransferase: cDNA cloning and expression, gene cloning, and chromosomal localization.

M A Thompson1, E Moon, U J Kim, J Xu, M J Siciliano, R M Weinshilboum.   

Abstract

Indolethylamine N-methyltransferase (INMT) catalyzes the N-methylation of tryptamine and structurally related compounds. We recently cloned and characterized the rabbit INMT cDNA and gene as a step toward cloning the cDNA and gene for this enzyme in humans. We have now used a PCR-based approach to clone a human INMT cDNA that had a 792-bp open reading frame that encoded a 263-amino-acid protein 88% identical in sequence to rabbit INMT. Northern blot analysis of 35 tissues showed that a 2.7-kb INMT mRNA species was expressed in most tissues. When the cDNA was expressed in COS-1 cells, the recombinant enzyme catalyzed the methylation of tryptamine with an apparent K(m) value of 2.9 mM. The human cDNA was then used to clone the human INMT gene from a human genomic BAC library. The gene was 5471 bp in length, consisted of three exons, and was structurally similar to the rabbit INMT gene as well as genes for nicotinamide N-methyltransferase and phenylethanolamine N-methyltransferase in several species. All INMT exon-intron splice junctions conformed to the "GT-AG" rule, and no canonical TATA or CAAT sequences were present within the 5'-flanking region of the gene. Human INMT mapped to chromosome 7p15.2-p15.3 on the basis of both PCR analysis and fluorescence in situ hybridization. Finally, two possible single nucleotide polymorphisms were identified within exon 3, both of which altered the encoded amino acid. The cloning and expression of a human INMT cDNA, as well as the cloning, structural characterization, and mapping of its gene represent steps toward future studies of the function and regulation of this methyltransferase enzyme in humans. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10552930     DOI: 10.1006/geno.1999.5960

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  24 in total

Review 1.  On the transmethylation hypothesis: stress, N,N-dimethyltryptamine, and positive symptoms of psychosis.

Authors:  Dionysios Grammenos; Steven A Barker
Journal:  J Neural Transm (Vienna)       Date:  2014-11-02       Impact factor: 3.575

2.  An (R)-specific N-methyltransferase involved in human morphine biosynthesis.

Authors:  Nadja Grobe; Xuan Ren; Toni M Kutchan; Meinhart H Zenk
Journal:  Arch Biochem Biophys       Date:  2010-11-17       Impact factor: 4.013

Review 3.  Pharmacogenomics: catechol O-methyltransferase to thiopurine S-methyltransferase.

Authors:  Richard M Weinshilboum
Journal:  Cell Mol Neurobiol       Date:  2006-06-29       Impact factor: 5.046

Review 4.  Clinical applications of hallucinogens: A review.

Authors:  Albert Garcia-Romeu; Brennan Kersgaard; Peter H Addy
Journal:  Exp Clin Psychopharmacol       Date:  2016-08       Impact factor: 3.157

Review 5.  Effect of Hallucinogens on Unconditioned Behavior.

Authors:  Adam L Halberstadt; Mark A Geyer
Journal:  Curr Top Behav Neurosci       Date:  2018

Review 6.  A possibly sigma-1 receptor mediated role of dimethyltryptamine in tissue protection, regeneration, and immunity.

Authors:  Ede Frecska; Attila Szabo; Michael J Winkelman; Luis E Luna; Dennis J McKenna
Journal:  J Neural Transm (Vienna)       Date:  2013-04-26       Impact factor: 3.575

7.  Human S-adenosylhomocysteine hydrolase: common gene sequence variation and functional genomic characterization.

Authors:  Qiping Feng; Mani Keshtgarpour; Linda L Pelleymounter; Irene Moon; Krishna R Kalari; Bruce W Eckloff; Eric D Wieben; Richard M Weinshilboum
Journal:  J Neurochem       Date:  2009-07-08       Impact factor: 5.372

Review 8.  Neuropharmacology of N,N-dimethyltryptamine.

Authors:  Theresa M Carbonaro; Michael B Gatch
Journal:  Brain Res Bull       Date:  2016-04-25       Impact factor: 4.077

9.  Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter.

Authors:  Nicholas V Cozzi; Anupama Gopalakrishnan; Lyndsey L Anderson; Joel T Feih; Alexander T Shulgin; Paul F Daley; Arnold E Ruoho
Journal:  J Neural Transm (Vienna)       Date:  2009-09-12       Impact factor: 3.575

10.  Macrocyclic Peptides as a Novel Class of NNMT Inhibitors: A SAR Study Aimed at Inhibitory Activity in the Cell.

Authors:  Kyohei Hayashi; Shota Uehara; Shiho Yamamoto; Douglas R Cary; Junichi Nishikawa; Taichi Ueda; Hiroki Ozasa; Kousuke Mihara; Norito Yoshimura; Taeko Kawai; Takashi Ono; Saki Yamamoto; Masataka Fumoto; Hidenori Mikamiyama
Journal:  ACS Med Chem Lett       Date:  2021-06-02       Impact factor: 4.632

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.